Antitrust

Despite a guilty plea, a new book by a former FBI agent claims the Idaho Murders case is far from closed, citing flaws in DNA and police work.

With 96% participation in a key debt exchange, the mining giant sidesteps a costly clause from its New Gold acquisition, showcasing shrewd financial strategy.

As new federal loan limits loom, a unique partnership offers a financial lifeline to future doctors, aiming to combat the growing physician shortage.

As China surpasses the US in key research metrics, a new English platform aims to bridge the information gap for global scientists and innovators.

Jeffrey Hollender's new book reveals the untold story of building a green empire, the pain of being fired, and the fight to keep a mission alive.

At the IDC CIO Summit, Ant Digital Technologies revealed a complete AI ecosystem, from foundation models to finance-grade agents, signaling a major push in ASEAN.

Dubai's AIR, owner of Al Fakher, is going public via a SPAC merger. Can it navigate a tricky market and health debates to find growth on Wall Street?

As Precigen leaders prepare for a key investor chat, all eyes are on the explosive launch of PAPZIMEOS and the company's ambitious path to profitability.

Avory & Co. enters the crowded ETF market with AVRY, an actively managed fund shunning trends for a concentrated portfolio of high-quality stocks.

Beijing hails Xizang's economic boom, but critics point to a deep erosion of culture and rights. What is the true story of development on the roof of the world?

A multi-billion dollar tender for Argentina's main trade artery pits a US-backed group against a rival with alleged hidden ties to Chinese state firms.

As Milestone Scientific prepares its year-end call, investors look for signs of a turnaround and growth for its advanced injection technology.

GrafTech's major price increase on a key steelmaking component signals a market shift, putting new pressure on electric arc furnace steel producers.

A federal judge's ruling allows a lawsuit to proceed over an alleged $2.2B valuation gap, placing the secretive world of corporate appraisal under a microscope.

A new report from a defense tech firm warns that AI tools can't replace engineers in complex government systems, citing major security and architectural risks.

A scathing report from Spruce Point Capital alleges Bunge's massive Viterra deal has failed, exposing deep financial strain and questionable accounting.

Two top federal prosecutors are leaving the DOJ to lead a Miami firm's D.C. expansion, challenging the established order of white-collar defense.

Apimeds Pharmaceuticals accuses its Korean partner of an illegal board seizure, sparking a high-stakes legal fight in Delaware and Seoul over a broken merger.

A new alliance between Discovery Life Sciences and Mindpeak aims to solve inconsistent biomarker interpretation, a critical bottleneck in cancer drug development.

Dr. Chidebelu Ufodike brings large-scale retail healthcare expertise to NJ Urology, signaling a strategic push for operational efficiency and expansion.